Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study

NCT04313660 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

NSCLC
Anlotinib
PD-1/L1 Inhibitor

Interventions

DRUG: Anlotinib In Combination With PD-1/L1 Inhibitor

Sponsor

Xiaorong Dong